Overview
Safety of Larazotide Acetate in Healthy Volunteers
Status:
Completed
Completed
Trial end date:
2006-02-27
2006-02-27
Target enrollment:
0
0
Participant gender:
All
All
Summary
To demonstrate the safety, tolerance and pharmacokinetics of multiple, oral doses of larazotide acetate.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
9 Meters Biopharma, Inc.
Alba Therapeutics
Criteria
Inclusion Criteria:- Healthy male and female subjects
- BMI between 18 and 30.
Exclusion Criteria:
- Subjects with clinically significant abnormal clinical lab results
- Hemoglobin < 12g/dL
- Subjects with diarrhea within 3 days prior to treatment visit